Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707811 · ClinicalTrials.gov registry record
Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 82
- Enrollment target
NCT00707811 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 82 participants.
The verdict
NCT00707811 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
Trouble breathing (dyspnea) is a nonspecific symptom associated with many diseases such as chronic obstructive pulmonary disease (lung disorder in which the flow of air to the lungs is blocked), asthma, pneumonia, pulmonary hypertension (high blood pressure in the lungs), congestive heart failure (fluid build-up in the lungs because the heart is not pumping normally) and pulmonary embolism (blood clot in the lungs). The purpose of this study is to test two blood markers called ST2 and IL-33. Blood markers are proteins or other compounds in your blood that physicians use to diagnose different diseases and to determine what the course of an illness will be. In preliminary research studies, ST2 and IL-33 have been elevated in patients with a wide variety of diseases where the lungs are the primary organs involved. This research study will further investigate the ability of ST2 and IL-33 to predict the severity of disease and the possible use of ST2 and IL-33 in the diagnosis of various lung diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707811
The ClinicalTrials.gov registry entry for NCT00707811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00707811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707811 about?
NCT00707811 is a clinical study titled "Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing". Trouble breathing (dyspnea) is a nonspecific symptom associated with many diseases such as chronic obstructive pulmonary disease (lung disorder in which the flow of air to the lungs is blocked), asthma, pneumonia, pulmonary hypertension (high blood pressure in the lungs), congestive heart failure (f...
What is the current status of trial NCT00707811?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2008-04. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00707811?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.